Pacer Advisors Inc. Has $1.68 Million Stake in Healthpeak Properties, Inc. $DOC

Pacer Advisors Inc. increased its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 87.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 102,445 shares of the real estate investment trust’s stock after acquiring an additional 47,729 shares during the quarter. Pacer Advisors Inc.’s holdings in Healthpeak Properties were worth $1,683,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Norges Bank bought a new position in Healthpeak Properties during the fourth quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of Healthpeak Properties by 60.3% during the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after purchasing an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Healthpeak Properties by 27.5% in the 1st quarter. Bank of America Corp DE now owns 11,887,795 shares of the real estate investment trust’s stock valued at $195,316,000 after buying an additional 2,563,407 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Insider Buying and Selling

In related news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.23% of the company’s stock.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $21.37 on Friday. The stock has a market cap of $14.73 billion, a price-to-earnings ratio of 61.07, a PEG ratio of 3.31 and a beta of 1.01. The company has a debt-to-equity ratio of 1.06, a quick ratio of 2.96 and a current ratio of 3.02. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The firm’s 50-day simple moving average is $21.20 and its 200 day simple moving average is $18.80.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, topping the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. During the same period in the prior year, the business posted $0.46 earnings per share. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts anticipate that Healthpeak Properties, Inc. will post 1.76 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio is 348.57%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on DOC shares. Cantor Fitzgerald upped their price target on Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research note on Thursday. Royal Bank Of Canada boosted their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a report on Thursday, May 14th. Scotiabank upped their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Wednesday, May 27th. Robert W. Baird increased their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Finally, Citigroup lifted their price target on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Four investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $20.97.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.